TrialCPT: pharmacometrics & systems pharmacology2024

Population pharmacokinetics and exposure-response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study.

Rong Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.